ZELAN has announced that it is now an affected listed issuer under Practice Note 17 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad.
The Company has triggered the prescribed criteria of Practice Note 17 of the Listing Requirements whereby the company’s external auditors, have expressed a disclaimer of opinion in the company’s audited financial statements for the financial year ended 31 December 2022 announced on 30 April 2023.
Zelan has 12 months to submit its regularisation plans.
As of the date of this announcement, Zelan said it is taking the necessary steps to address its PN17 status and is in the midst of formulating a plan to regularise its financial condition.
